SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000043
Filing Date
2024-01-09
Accepted
2024-01-09 16:30:13
Documents
16
Period of Report
2024-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 26672
2 CONSULTING AGREEMENT, DATED JANUARY 8, 2024, BY AND BETWEEN OPGEN, INC. AND ALBE ex10x1.htm EX-10.1 55536
3 CONSULTING AGREEMENT, DATED JANUARY 8, 2024, BY AND BETWEEN OPGEN, INC. AND JOHA ex10x2.htm EX-10.2 55901
4 GRAPHIC image_001.jpg GRAPHIC 3853
5 GRAPHIC image_002.gif GRAPHIC 3349
  Complete submission text file 0001079973-24-000043.txt   350330

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE opgn-20240104.xsd EX-101.SCH 3006
7 XBRL LABEL FILE opgn-20240104_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE opgn-20240104_pre.xml EX-101.PRE 22353
10 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3275
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 24523627
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)